http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015197426-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05c62f2cf821f016678afe25fbcd6ced |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate | 2014-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb69a7aa4bdeda24ae67ae7d36b9cfca http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc642cde00448aae5d1f1a1a22da33b3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fb4df71c2c6e25c9347d36f7156d016 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_598c6424b251eb60bebb00b57ffe1a02 |
| publicationDate | 2015-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2015197426-A |
| titleOfInvention | Biomarker |
| abstract | The present invention provides a biomarker capable of accurately distinguishing from an infectious disease in medical treatment of autoimmune diseases. [MEANS FOR SOLVING PROBLEMS] A biomarker for distinguishing autoimmune diseases with high disease activity from complications of autoimmune diseases and infectious diseases, and the expression level of CD64 expressed in monocytes / expressed in neutrophils The expression ratio of the expression level of CD64. When the autoimmune disease is systemic lupus erythematosus, it is a complication when the ratio of the expression level of CD64 expressed in monocytes / the expression level of CD64 expressed in neutrophils is 7.2 to 3.0. Cases 15.0 to 4.7 are systemic lupus erythematosus with high disease activity. [Selection] Figure 3 |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11726089-B2 |
| priorityDate | 2014-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 56.